🇺🇸 FDA
Patent

US 10647754

Stabilized single human CD4 domains and fusion proteins

granted A61KA61K38/00A61K38/162

Quick answer

US patent 10647754 (Stabilized single human CD4 domains and fusion proteins) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00, A61K38/162, A61K38/1774, A61K47/6425